Tech Transfer Is Not A Handoff

This segment of the Outsourced Pharma Live event, “Beyond Data Packages: De-Risking Tech Transfer To CDMOs,” closes with practical advice for making tech transfer more predictable, including the value of digital process tools, video-based process capture, digital twins, and in silico models. Darren and Bikash emphasize that tech transfer should be treated as one part of a larger roadmap to process understanding, CDMO alignment, and pre-approval inspection readiness, not a single handoff event. Featuring Darren Dasburg, CEO, Clarus Biologics, and Bikash Chatterjee, President and CSO, Pharmatech Associates.